When CAR-T cells specific for CD22 were analyzed for either CD22 or CD19 acquisition following co-culture with leukemia target cells, CD19 appeared to transfer more readily to the CAR-T cell surface than CD22. The gene discussed is CD22; the disease is leukemia.